Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | February 2023
The return now follows the consultation proposals and includes a new tier-focussed section based on total liabilities in the last s179 valuation. The amount of information schemes are required to provide is assessed on the following asset tiers:
Tiers 2 and 3 are required to provide more detailed information on the bonds and equities held by the scheme. Tier 3 must also provide information on risk factors in line with PPF rules. The Regulator states that this information will help it assess a scheme's investment risk more accurately and provide the PPF with more detailed information to calculate the levy invoice. The new asset information will need to be collated and submitted to the Regulator before the March 31, 2023, deadline, and trustees will need to discuss these new requirements with their investment advisers. The Regulator will also conduct an exercise this year to check whether schemes carry out their duties to publish the statement of investment principles and implementation statements. It asks schemes to ensure that they respond to the relevant questions in the return on environmental, social and governance and climate change.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025